https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.optometricmanagement.com/media/350a2t1i/1126-cover.jpg
Contact Lens Spectrum
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.optometricmanagement.com/media/zf0kqy3n/cover1.jpg
Eyecare Business
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.optometricmanagement.com/media/nabeii2w/om-novdec-2026-cover.jpg
Optometric Management
Monday, November 2, 2026
The initiative builds on existing partnerships that have provided vision screenings and care to nearly 60 million children and helped restore sight to more than 70,000 cataract patients, the company said.
Monday, November 2, 2026
The new assistant uses AI to interpret visual information and respond to natural-language requests to support everyday activities.
Monday, November 2, 2026
The platform enables eyecare professionals to access Harrow’s entire portfolio through existing electronic medical record systems.
Thursday, October 29, 2026
"Vision loss from diabetes is not inevitable, but protecting sight requires awareness, access to care, and early action,” says Prevent Blindness president and CEO Jeff Todd.
Thursday, October 29, 2026
The QuickSet TKP is designed to facilitate posterior-segment visualization while maintaining a closed system for vitrectomy.
Wednesday, October 28, 2026
Updates on pivotal SYD-101-001 trial data.
Wednesday, October 28, 2026
A phase 3 study involving 582 patients demonstrated equivalent efficacy and comparable safety to reference ranibizumab.
Tuesday, October 27, 2026
See the recall for a full list of lot numbers.
Tuesday, October 27, 2026
The conference will feature an expanded continuing education program, new peer-to-peer learning opportunities, and sessions that will address clinical care, practice management, leadership, and business growth.
Friday, October 23, 2026
Many parents may misunderstand prevention strategies, symptoms to look out for, and management with spectacle lenses.
Wednesday, October 21, 2026
Federal judge certifies California consumer lawsuit alleging unauthorized contact lens substitutions and improper prescription verification.
Wednesday, October 21, 2026
Both CLARITY trials met their primary endpoints, with significant improvements in treatment failure and steroid-free disease control.
Wednesday, October 21, 2026
Encelto is an encapsulated cell therapy that is intended for surgical intravitreal implantation.
Monday, October 19, 2026
Randomization is complete in the 176-patient PREDICT-1 registrational trial evaluating licaminlimab for dry eye disease, with topline results expected by year-end 2026.
Monday, October 19, 2026
Four-year results from a first-in-human trial showed a 37% reduction in mean IOP, with 86% of evaluable patients remaining off topical IOP-lowering medications.
Monday, October 19, 2026
Following the failure of its second pivotal Duravyu trial to demonstrate noninferiority to aflibercept, EyePoint plans to cut its workforce by 53% and terminate its nAMD trials early.
Monday, October 19, 2026
Two counterfeit eye drop products tested positive for bacterial contamination, raising concerns about serious eye infections and potential vision loss.
Monday, October 19, 2026
The expanded indication is supported by positive results from the pivotal phase 3 VEGA-2 and VEGA-3 clinical trials.
Friday, October 16, 2026
Brytly is approved for adults and children ages 12 years and older and should not be used more than twice daily.
Friday, October 16, 2026
New educational resources on inflammatory eye diseases, including uveitis, keratitis, conjunctivitis, and thyroid eye disease are being highlighted from October 19 to 25, 2026.
Friday, October 16, 2026
The Vision Council Foundation and KidSight partnered to provide free vision screenings to 1,309 children in recognition of World Sight Day.
Friday, October 16, 2026
Genentech’s IL-6 receptor inhibitor becomes the first subcutaneous treatment approved for TED, with at-home administration every 4 weeks during maintenance.
Thursday, October 15, 2026
The agency is seeking public comment on a proposal to extend the information-collection requirements of its Contact Lens Rule for an additional 3 years.
Thursday, October 15, 2026
EyeDock AI is a clinical assistant for optometrists, ophthalmologists, opticians, and students.
Wednesday, October 14, 2026
My Euclid brings topography-guided lens fitting, ordering, patient management and expert consultation into one connected workflow.
Tuesday, October 13, 2026
Wider language accessibility can help eyecare professionals recognize dry eye symptoms, counsel patients, and provide individualized care based on clinical judgment.
Friday, October 9, 2026
The study will evaluate how ST-100 supports epithelial and stromal healing in corneal wounds.
Friday, October 9, 2026
The deal will add IOL simulation for cataract surgery to the Carrot Platform and expand Carrot from vision diagnostics into vision simulation.
Friday, October 9, 2026
The study met its primary efficacy endpoint, demonstrating statistically significant superiority and clinically meaningful IOP reduction vs cataract surgery alone, according to the company.
Thursday, October 8, 2026
The award is intended to recognize both the immediate impact of providing treatment for blindness and longer-term investments in the workforce, facilities, and health systems needed to expand access to eye care.
Thursday, October 8, 2026
He plans to work with the company’s leadership team to support its continued growth and long-term development.
Thursday, October 8, 2026
PIONEER trial findings show improvements in light sensitivity and measures of visual function in some patients with late-stage retinitis pigmentosa.
Thursday, October 8, 2026
Three researchers were recognized for pioneering discoveries that transformed the study of neural circuits and opened new avenues for restoring vision.
Thursday, October 8, 2026
Six-month data on a new bioreinforced canaloplasty procedure show 37% IOP reduction, with new findings on bioreinforced cyclodialysis to be presented at AAO 2026.
Thursday, October 8, 2026
Glaukos has entered into an exclusive license agreement with RevOpsis Therapeutics, Inc. to develop and commercialize RO-104, a novel trispecific biologic.
Thursday, October 8, 2026
The extension study followed a cohort of patients for 3 years after cross-linking treatment in Epioxa’s second phase 3 pivotal trial (GLK-202-02).
Wednesday, October 7, 2026
The nonprofit marked the milestone while launching an effort to provide needed glasses to children in Los Angeles Unified Community Schools.
Wednesday, October 7, 2026
Many parents were only somewhat confident that they would notice a problem with their child's vision.
Wednesday, October 7, 2026
The device combines redesigned aspheric optics, updated coatings, and a lighter design intended to support retinal visualization during diagnosis and treatment.
Wednesday, October 7, 2026
A post hoc analysis showed reduced growth rates across several optical coherence tomography biomarkers after treatment.
Tuesday, October 6, 2026
Launched from Topcon Healthcare, Oku combines AI, retinal imaging, and connected clinical data to identify disease risk earlier.
Tuesday, October 6, 2026
Harrow acquired worldwide rights to the dry eye treatment, excluding Japan.
Friday, October 2, 2026
Systane Pro Preservative-Free demonstrated noninferiority to Miebo in relieving dry eye symptoms at 2 weeks and 1 month, according to Alcon.
Friday, October 2, 2026
According to GlassesUSA.com, the hub brings expert guidance to some of the most common questions about prescriptions, lenses, and eye health.
Friday, October 2, 2026
A survey of 1,089 US adults found that eye fatigue after screen use is common, while awareness of digital eye strain and dry eye disease remains limited.
Friday, October 2, 2026
Outlook Therapeutics has applied to the CMS for a permanent, product-specific HCPCS Level II J-code for Lytenava, as the company prepares to launch the wet AMD treatment in the United States.
Friday, October 2, 2026
Omni Ultra enables single pass canaloplasty followed by trabeculotomy while also featuring TruSync Plus technology and enhanced catheter visualization.
Thursday, October 1, 2026
Orthokeratologist.org has launched as a dedicated global platform for orthokeratology practitioners, with an initiative to build a worldwide database.
Thursday, October 1, 2026
The proposed legislation would broaden screening coverage for people at increased risk and provide funding for community-based programs and glaucoma research.
Thursday, October 1, 2026
New Medicare coding and payment determinations for Balance Ophthalmics’ FSYX Ocular Pressure Adjusting Pump take effect October 1, establishing separate HCPCS Level II codes for the pump and its goggles.
Thursday, October 1, 2026
The approach uses retinal imaging to create a lesion-specific testing grid for each patient, with microperimetry measuring sensitivity at locations surrounding the atrophic area.
Wednesday, September 30, 2026
This year's event focused on strategies to fit and troubleshoot scleral lenses and centered on a staple of FitAcademy programs.
Wednesday, September 30, 2026
Optometry Giving Sight announced the recipients of its 2026 grant cycle, awarding nearly $1 million to 20 organizations working to bring sustainable primary eye care to communities around the world.
Wednesday, September 30, 2026
New research from CooperVision suggests that vision remains an overlooked, yet high-potential part of the healthy aging conversation as consumers increasingly invest in products and services that help them look and feel younger.
Tuesday, September 29, 2026
The company announced its intent to submit to the FDA a Formal Dispute Resolution Request for reproxalap, an investigational drug candidate for the treatment of dry eye disease.
Monday, September 28, 2026
The organization is emphasizing safe lens use and warning against nonprescription decorative contacts.
Monday, September 28, 2026
The acquisition includes Clarkson Eyecare, EyeCare Associates, EyeCare Center, Nationwide Vision, and The Eye Doctors.
Monday, September 28, 2026
Both investigational therapies met the primary endpoint for noninferiority to aflibercept in vision gains at 1 year.
Monday, September 28, 2026
Galaxy features a spiral design engineered to reduce halo and glare, the company said.
Monday, September 28, 2026
SYD-101 is an investigational low-dose atropine formulation for pediatric progressive myopia.
Friday, September 25, 2026
The travel grants are designed to recognize emerging leaders in specialty.
Thursday, September 24, 2026
Remigromig demonstrated noninferiority to active control ranibizumab for mean change from baseline in best-corrected visual acuity at week 52.
Thursday, September 24, 2026
The Class II recall addresses a stability issue that could cause the imaging system’s stand to tip over during movement.
Wednesday, September 23, 2026
The Class II recall involves one lot containing lenses with the incorrect power.
Wednesday, September 23, 2026
Retirees can use the Medicare Open Enrollment period to review whether their existing benefits address routine vision care needs.
Wednesday, September 23, 2026
The indocyanine green injection is now commercially available for ophthalmic angiography and other medical procedures.
Wednesday, September 23, 2026
AURN001 is a potential first-in-class investigational combination therapy for corneal endothelial disease, including Fuchs dystrophy, the company said.
Thursday, September 17, 2026
This year will include vision screenings, educational programs, professional resources, and a new continuing education opportunity for optometrists, as well as continued advocacy in Congress.
Tuesday, September 15, 2026
Learn more about the peer-to-peer education series and Lumenis technologies from our Chicago coverage.
Sunday, September 13, 2026
He will lead the company's global business development and corporate strategy team.
Friday, September 11, 2026
Study among young women who regularly have eyelash extensions found that most have Demodex folliculorum
Thursday, September 10, 2026
Now in its 11th year, the competition invites photographers around the globe to share images that celebrate eye health and the role vision plays in everyday life.
Wednesday, September 9, 2026
The award recognizes an individual whose inspired outlook champions healthy vision and its importance for a healthy life.
Wednesday, September 9, 2026
The resolution also calls for increased public health education and improved screening in children.
Wednesday, September 9, 2026
The award recognizes DOT lenses' novel contrast management approach to slowing myopia progression in children
Tuesday, September 8, 2026
The acquisition adds gildeuretinol (ALK-001), a phase 3 oral investigational medicine designed to target the underlying biology of Stargardt disease
Tuesday, September 8, 2026
The new Mix and Match feature allows surgeons to simulate different IOL combinations between each eye, helping patients experience personalized vision strategies before cataract surgery
Tuesday, September 8, 2026
PretestPro runs 4 eye exams in a single workflow on the Heru Prime wearable platform.
Tuesday, September 8, 2026
Unity M has received CE Mark and regulatory approvals in India, Europe, Canada, Japan, and the United States, with inventory beginning to ship in September.
Thursday, September 3, 2026
The letter-matching test reduced referrals and improved screening performance among preschool children compared with tumbling E.
Wednesday, September 2, 2026
The Challenge unites a global community of optometry practices, schools, students, and industry partners in raising funds to bring sustainable vision care to communities without access.
Tuesday, September 1, 2026
According to the survey, only 14% of perimenopausal, menopausal, and postmenopausal women recognize dry eye as a menopause-related symptom.
Monday, August 31, 2026
Lunara is manufactured in Optimum Infinite (tisilfocon A), a 180 Dk material that provides high oxygen permeability for overnight wear.
Friday, August 28, 2026
A randomized US trial found reduced refractive progression and axial elongation over 2 years with highly aspherical lenslets.
Thursday, August 27, 2026
To help educate the public on the importance of wearing proper eye protection while playing sports, Prevent Blindness offers free sports eye safety information including a dedicated webpage, fact sheets, and shareable social media graphics.
Thursday, August 27, 2026
The system is expected to become available in selected European countries from September 2026, with wider global availability to follow.
Tuesday, August 25, 2026
TRPV1 antagonist met the primary endpoint in a capsaicin-induced pain model, with phase 2 results expected in the coming months.
Tuesday, August 25, 2026
Phase 2 results support advancement to phase 3 with a primary endpoint at day 15.
Tuesday, August 25, 2026
“Eye exams belong on every family's back-to-school checklist, right alongside shopping for new clothes and school supplies,” says Ashley Mills, CEO of The Vision Council and The Vision Council Foundation.
Monday, August 24, 2026
The over-the-counter eye drop was voluntarily recalled nationwide due to a lack of assurance of sterility and potential contamination.
Monday, August 24, 2026
The authorization establishes a defined FDA-recognized classification for Avulux, which is designed to help manage light sensitivity associated with migraine.
Thursday, August 20, 2026
Expanded label makes TearCare the first and only MGD treatment indicated to improve meibomian gland function in adults with evaporative dry eye disease, according to Sight Sciences.
Wednesday, August 19, 2026
Next steps include human testing in participating day care centers.
Wednesday, August 19, 2026
Zeiss Clinic 360 is part of the Zeiss ophthalmic workflow portfolio and will be available in the United States in early Fall 2026.
Wednesday, August 19, 2026
IACLE members can gain direct access from the IACLE Teaching Online Platform learning management system.
Wednesday, August 19, 2026
Findings demonstrate corneal epithelial resolution in all eyes with complete follow-up, supporting decellularized basement membrane as an earlier intervention option for neurotrophic keratitis patients.
Wednesday, August 19, 2026
The study missed its primary endpoint in the full dataset but met several secondary endpoints.
Wednesday, August 19, 2026
CMS established reimbursement for the Fsyx pump and goggles ahead of a planned fourth-quarter commercial launch.
Friday, August 14, 2026
Click here to register for this free virtual CE.
Tuesday, August 11, 2026
Collaboration will enable ophthalmologists and optometrists to pair wavefront-guided diagnostics with scleral lens options.
Friday, August 7, 2026
Gildeuretinol (ALK-001) is an investigational once-daily oral therapy currently being evaluated in a phase 3 trial for Stargardt disease.
Thursday, August 6, 2026
Click here to register for this free virtual CE.
Thursday, August 6, 2026
Manufactured by Visco, Classic 2.0 contains 57% water and is designed to help maintain hydration throughout the day.
Thursday, August 6, 2026
This year’s focus reflects the organization’s commitment to providing a comprehensive understanding of keratoconus, while highlighting the multidisciplinary collaboration required to provide the best possible patient outcomes.
Thursday, August 6, 2026
The acquisition expands the company's dry eye portfolio.
Wednesday, August 5, 2026
Yesafili, a vascular endothelial growth factor (VEGF) inhibitor used to treat various types of ophthalmology conditions, is a biosimilar of its reference product Eylea (aflibercept 2 mg; Regeneron).
Wednesday, August 5, 2026
PROSE devices were previously not studied in neurotrophic keratitis, though they have demonstrated therapeutic benefits in a range of other ocular surface diseases.
Wednesday, August 5, 2026
The system is the first FDA-cleared MIGS device for single pass canaloplasty with TruSync Plus, according to the company.
Tuesday, August 4, 2026
The over-the-counter Rohto Cooling Eye Drops were voluntarily recalled nationwide due to a lack of assurance of sterility.
Wednesday, July 29, 2026
This year's World Sight Day Challenge has the theme "It's not just sight. It's an entire future.”
Wednesday, July 29, 2026
A new analysis of US eyecare practices suggests that patients who wear soft contact lenses generate greater annual practice profitability than comparable patients who wear glasses alone.
Monday, July 27, 2026
Benefits to visual function and structural markers vary by intervention.
Friday, July 24, 2026
The FDA has approved Lytenava (bevacizumab-vikg; Outlook Therapeutics) for the treatment of neovascular age-related macular degeneration, making it the first FDA-approved ophthalmic formulation of bevacizumab in the United States.
Friday, July 24, 2026
The $1,500 travel grants were awarded to attend Academy 2026 in Anaheim, California.
Friday, July 24, 2026
The EyeMed Cares Disaster Relief Replacement Program is designed to help members quickly restore access to vision care while simplifying the process for eyecare providers.
Thursday, July 23, 2026
The expert-approved training course provides evidence-based screening practices to help catch vision impairments in children early and connect them directly to eye care.
Wednesday, July 22, 2026
The research aims to collect anterior segment eye images through the high-definition camera on a smartphone using Deya Imaging.
Tuesday, July 21, 2026
In the 0.7 mg cohort, the mean rate of geographic atrophy growth was 54% lower than in the pooled group of control eyes over 6 months.
Tuesday, July 21, 2026
The virtual reality ophthalmic training program supports hands-on training in regions of Africa where access to surgical training resources and mentorship opportunities can be limited.
Monday, July 20, 2026
The therapy improved visual acuity and stereoacuity in patients who have amblyopia, particularly older children who had not benefited from prolonged patching therapy.
Thursday, July 16, 2026
The EyeGility Inserter is now available in the US as part of the enVista Aspire preloaded IOLs.
Wednesday, July 15, 2026
The platform is intended to streamline the fitting process for patients who have irregular corneas and require custom rigid GP lenses.
Wednesday, July 15, 2026
The AAO has announced the recipients of its 2026 awards, recognizing individuals and organizations for contributions to research, education, clinical care, leadership, humanitarian service, and the advancement of optometry.
Wednesday, July 15, 2026
Proposed changes to the Physician Fee Schedule include lower conversion factors, E/M payment revisions, and practice expense reforms.
Tuesday, July 14, 2026
Zhaoke Ophthalmology Limited announced the signing of a definitive agreement to acquire global rights to NVK002, a proprietary low-concentration atropine formulation for slowing myopia progression.
Monday, July 13, 2026
The study did not achieve its primary endpoint of replicating visual function improvements observed in a smaller phase 1/2a study following 28 days of topical administration for glaucoma.
Monday, July 13, 2026
The new platform is designed to reduce the operational burden that stands between physicians and their patients, Bausch + Lomb said.
Friday, July 10, 2026
IRX-101 is an investigational ocular antiseptic with the potential to improve the standard of care by reducing postprocedural pain and corneal toxicity in patients receiving intravitreal therapy, said Tarsus Pharmaceuticals.
Friday, July 10, 2026
Prednisolone acetate ophthalmic suspension, USP, 1%, manufactured by Lupin Limited, has been recalled due to the presence of a foreign substance.
Thursday, July 9, 2026
Parents recognize vision is key to school success, yet many teens aren’t getting eye exams, according to an Alcon survey
Thursday, July 9, 2026
Public comment period begins July 6 for evidence-based guideline supporting comprehensive pediatric eye and vision care
Thursday, July 9, 2026
The updated lineup now includes ABB Verify Validate and Engage by ABB Verify.
Thursday, July 9, 2026
Submit abstracts here.
Wednesday, July 8, 2026
Accessible through VIZZ.com, the integrated telehealth platform connects patients with an independent network of licensed ECPs who will evaluate patient telehealth eligibility based upon their medical history.
Wednesday, July 8, 2026
A new study from Orbis International found that by combining a free smartphone app focused on quality improvement with an investment of $2,500, 11 hospitals in Ethiopia nearly doubled their cataract surgery success rates.
Tuesday, July 7, 2026
EO2002 is the company’s lead investigational magnetic human corneal endothelial cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.
Tuesday, July 7, 2026
The companies will create a codeveloped technology that enables surgeons to fine-tune visual outcomes for their cataract patients who choose a PCIOL.
Thursday, July 2, 2026
Byooviz (ranibizumab-nuna) is a biosimilar referencing ranibizumab (Lucentis; Genentech).
Wednesday, July 1, 2026
LambdaVision is harnessing the unique space environment to manufacture artificial retinas to restore vision to people blinded by macular degeneration.
Wednesday, July 1, 2026
Aurora GP Lab Inc. has launched as a specialty ophthalmic device manufacturer focused on custom rigid GP contact lenses, including orthokeratology (ortho-k) and scleral lens technologies.
Wednesday, July 1, 2026
The Ohio State University has selected Jeffrey J. Walline, OD, PhD, as its sixth College of Optometry dean, effective July 1, pending board of trustees approval.
Wednesday, July 1, 2026
New survey findings show the impact of dry eye can extend beyond the burden of physical symptoms, affecting how patients view their emotional health and wellbeing.
Tuesday, June 30, 2026
Results from the trial showed that nearly 9 out of 10 wearers rated CamberPure highly across clarity, comfort, and satisfaction.
Tuesday, June 30, 2026
The filing application is based on improvements seen across key efficacy endpoints from the global phase 3 SatraGO-1 and SatraGO-2 studies, including proptosis and diplopia in active TED.
Monday, June 29, 2026
The company has now fully enrolled both pivotal wet AMD studies ahead of initial projections. Topline data is expected in 2027.
Monday, June 29, 2026
Regenxbio and AbbVie advance suprachoroidal gene therapy sura-vec into phase 2b/3 testing for nonproliferative diabetic retinopathy.
Monday, June 29, 2026
The initiative aims to enhance training, consultation, and research in clinical perimetry by establishing a comprehensive educational program designed by the Casey Visual Field Reading Center.
Monday, June 29, 2026
The 510(k)-cleared system is the industry’s first wireless integrated laser indirect ophthalmoscope system.
Monday, June 29, 2026
The Optase line of products now includes Eyetamins Eye Comfort and Eyetamins Vision Support
Monday, June 29, 2026
Lumvoa is a full antagonist of IGF-1R and the first approved treatment for TED with labeling that includes data for both active and chronic TED, according to the company.
Friday, June 26, 2026
VSP Vision has named the recipients of its 2026 Propel Student Business Challenge Scholarship, recognizing optometry students for innovative, patient-centered private practice business plans.
Thursday, June 25, 2026
The company highlights global use of its ultra-widefield imaging technology.
Thursday, June 25, 2026
Among survey respondents, 65% said they were familiar with the potential effects of UV exposure on the eyes, but only 36% said they were concerned enough to change their behavior.
Thursday, June 25, 2026
The phase 2 study is evaluating an investigational eyelid-applied therapy for Demodex blepharitis.
Wednesday, June 24, 2026
Prevent Blindness has designated July as Dry Eye Month as part of an effort to raise awareness about dry eye disease, offering a variety of free educational resources eyecare professionals can share with their patients.
Tuesday, June 23, 2026
According to the company, the moisture-rich eye drop provides an economical alternative for long-term therapeutic use.
Tuesday, June 23, 2026
Both lenses are available through VSP, along with the full Sequel portfolio of lenses.
Tuesday, June 23, 2026
Bayer now holds the full rights pertaining to PER-001 intravitreal implant, a sustained release small molecule endothelin receptor antagonist currently in phase 2 clinical development for the treatment of glaucoma and diabetic retinopathy.
Tuesday, June 23, 2026
The collaboration aims to advance glaucoma care through gamified virtual reality (VR) technology and VR-based visual function testing.
Wednesday, June 17, 2026
Modern Optical International has launched Modern Vision for All, a charitable initiative aimed at supporting access to vision care for underserved families in the United States and internationally.
Wednesday, June 17, 2026
The 9-month professional development program is designed for recent optometry school graduates and early-career optometrists. Applications will be accepted through July 31.
Wednesday, June 17, 2026
Prevent Blindness has designated June 28 to July 4 as the sixth annual Fireworks Safety Week, an awareness campaign focused on educating the public about the risk of fireworks-related eye injuries ahead of Independence Day celebrations.
Wednesday, June 17, 2026
The annual recognition honors individuals or groups that have contributed to improving public health approaches to children’s vision and eye health in the United States.
Wednesday, June 17, 2026
The updates reflect the inclusion of dry eye etiological drivers, the OSDI-6 symptomatology questionnaire, and some new and refined management options.
Wednesday, June 17, 2026
The expanded portfolio of daily contact toric lenses will be available in the United States and Canada this summer.
Wednesday, June 17, 2026
The new Change Agents and Student Change Agents can be found on AOA.org.
Wednesday, June 17, 2026
Built with technology from the Brien Holden Vision Institute, the new multifocal-toric lens option combines the optical design and properties of Be Free Day spherical lenses with toric correction for patients with astigmatism.
Wednesday, June 17, 2026
Zolymbus (bimatoprost ophthalmic gel) 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Tuesday, June 16, 2026
The completion of all follow-up exams across both pivotal studies will allow Epion to advance toward regulatory submission to the FDA.
Tuesday, June 16, 2026
The product is available in 30- and 60-count single-use vials.
Friday, June 12, 2026
The annual scholarship awards $2,500 to a UC Berkeley optometry student who has completed the VSP Business Management Immersion Program (BMIP).
Friday, June 12, 2026
The Association of Schools and Colleges of Optometry (ASCO) has announced the recipients of its 2026 Special Recognition Awards, which honor individuals and organizations for contributions to optometric education, research, leadership, and patient care.
Thursday, June 11, 2026
Expanded US availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery
Thursday, June 11, 2026
The relaunch is intended to address access challenges for patients with vernal keratoconjunctivitis.
Wednesday, June 10, 2026
Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tears
Wednesday, June 10, 2026
The latest version is designed to deliver speed, workflow flexibility, and diagnostic depth to multimodal retinal imaging, the company said.
Tuesday, June 9, 2026
Orunea will enroll 150 adult patients to evaluate whether Cenegermin-bkbj can achieve complete epithelial healing of the cornea.
Tuesday, June 9, 2026
The study will assess gildeuretinol’s potential to reduce the growth rate of retinal atrophic lesions and to preserve visual acuity.
Tuesday, June 9, 2026
The draft guidance is intended to help developers of cell and gene therapies make greater use of existing scientific and regulatory knowledge when advancing new products.
Friday, June 5, 2026
A record number of students applied to Transitions Optical’s 2026 educational grant program, signaling a growing interest in the eyecare field. Seven students were selected by a panel of eyecare professionals for grants of $5,000 and $1,000.
Friday, June 5, 2026
Ranibizumab-hkdz, an interchangeable biosimilar to Lucentis, will be available in both vial and prefilled syringe formats.
Thursday, June 4, 2026
The Neuro-Optometric Rehabilitation Association International (NORA) has announced the opening of registration for its 2026 Annual Conference, scheduled for October 22-25 at the Hilton Peachtree City Atlanta Hotel & Conference Center in Peachtree City, Georgia.
Thursday, June 4, 2026
The funding will support the renovation of the Highway 301 building in Statesboro, Georgia, creating a facility designed to educate and train future doctors of optometry.
Thursday, June 4, 2026
Prevent Blindness is recognizing June as Cataract Month to raise awareness of the leading cause of vision loss in the United States.
Wednesday, June 3, 2026
According to Complement Therapeutics, Opti-GAIN investigators reported no significant safety concerns and advanced the gene therapy study to Cohort 2.
Tuesday, June 2, 2026
Blog post explores prevalence and impact on Hispanic/Latino patients during Cataract Awareness Month.
Monday, June 1, 2026
Patients with evaporative dry eye may find symptom relief.
Friday, May 29, 2026
The Professional Eye Care Associates of America (PECAA)’s Annual Meeting drew more than 1,200 attendees to San Diego, where the organization unveiled new initiatives ranging from an AI-focused certification course to expanded private practice resources.
Thursday, May 28, 2026
More than 2,300 parameters now available for next‑day shipping
Thursday, May 28, 2026
Cure Blindness Project has released its 2025 Impact Report, which details what the organization described as its most impactful year to date in efforts to eliminate avoidable blindness worldwide.
Thursday, May 28, 2026
The Vision Council Foundation, AccuWeather, and The Skin Cancer Foundation have announced a new collaboration ahead of National Sunglasses Day on June 27, focused on promoting comprehensive protection against ultraviolet radiation.
Tuesday, May 26, 2026
Next steps include a due diligence process to evaluate financial and legal obligations, programmatic integration opportunities, operational and staffing considerations, and continuity of member services and education.
Tuesday, May 26, 2026
The American Academy of Optometry Foundation (AAOF) and Meta Reality Labs Research (RLR)’s grant program supports longitudinal, open-science research focused on myopia development and progression.
Friday, May 22, 2026
Friday, May 22, 2026
The product is available in 30-count and 60-count 0.4 mL single-use vials
Tuesday, May 19, 2026
The novel anterior keratoplasty approach achieved sustained epithelialization and pain reduction in patients with nonhealing ocular surface disease.
Tuesday, May 19, 2026
The company’s PreserVision AREDS3 supplement combines AREDS2 nutrients with a proprietary B-vitamin complex intended to support macular health earlier in AMD.
Tuesday, May 19, 2026
The artificial tear is designed to deliver fast-acting temporary relief for individuals experiencing dry eye symptoms
Monday, May 18, 2026
Their approach uses a light-activated technology derived from the photosynthetic membranes of the spinach plant, which enables the eye to stay continuously hydrated.
Monday, May 18, 2026
The screening marked the launch of the new program, which is delivered through Siloam Vision's proprietary telemedicine platform, iTelegen, with ongoing research at the National Center for Maternal and Child Health neonatal intensive care unit in Ulaanbaatar, Mongolia.
Friday, May 15, 2026
The annual initiative promotes the use of UV-protective eyewear as part of everyday eye health and wellness practices.
Friday, May 15, 2026
Prevent Blindness will host its 2026 ASPECT Patient Engagement Summit and its Eyes on Capitol Hill Legislative Advocacy Day from June 7 to 10 in Washington, DC.
Thursday, May 14, 2026
Led by Damaris Raymondi, OD, and Coralys Vega, MD, the initiative brought together complementary clinical perspectives to reinforce myopia management as the emerging standard of care for children who have progressive myopia.
Wednesday, May 13, 2026
The tool’s professional and consumer platforms will be free to access.
Wednesday, May 13, 2026
Reductions in digital eye strain symptoms and high satisfaction scores for visual comfort and clarity were statistically significant, the company reported.
Wednesday, May 13, 2026
The connected system enables remote monitoring of overnight patient adherence.
Friday, May 8, 2026
The resource offers families a centralized, evidence-based guide to childhood myopia treatments, offering clear guidance to help parents and caregivers navigate the growing range of options for their children.
Friday, May 8, 2026
CooperVision has made available its MyDay Energys daily disposable contact lens in a new 180‑pack.
Friday, May 8, 2026
The American Optometric Association has revealed the recipients of its 2026 awards, recognizing optometrists, paraoptometrics, educators, students, and organizations for contributions to the profession and public eye health.
Friday, May 8, 2026
The report outlines the company’s progress on corporate social responsibility initiatives focused on health equity, sustainability, and inclusion.
Thursday, May 7, 2026
The study included children aged 4 to 12 years old, which Hoya says is a first.
Thursday, May 7, 2026
The MiSight 1 day Switch Guarantee is designed to help eyecare professionals transition children from single vision contact lenses into myopia control lenses.
Thursday, May 7, 2026
New clinical evidence demonstrates the effectiveness and safety of RevitalVision's perceptual learning software in improving visual function across multiple ophthalmic indications.
Thursday, May 7, 2026
Two-year study results from SightGlass Vision affirm high efficacy with contrast management
Thursday, May 7, 2026
Each Accelerate event offers facilitated breakout discussions, interactive demonstrations, and real-world case sharing.
Thursday, May 7, 2026
The acquisition of Perfuse Therapeutics includes PER-001, an intraocular implant in phase 2 trials for glaucoma and diabetic retinopathy.
Wednesday, May 6, 2026
Key outcome measures included axial length, retinal and choroidal thickness, and OCTA parameters.
Wednesday, May 6, 2026
Each company has ceased production with the manufacturer in question, and has said that only the lot numbers listed were affected.
Wednesday, May 6, 2026
The Clerra range includes single vision and progressive lenses across premium materials such as plastic, polycarbonate, Trivex, high index, and super thin designs.
Wednesday, May 6, 2026
Data from the study revealed gains in BCVA of +9 letters at 36 months among patients with extensive coverage of OpRegen cell therapy to the GA lesion site.
Tuesday, May 5, 2026
The May Cultural Responsiveness blog encourages ODs to prioritize communication with patients and their families.
Monday, May 4, 2026
The transaction is expected to close in early 2027.
Thursday, April 30, 2026
The approach is based on emmetropization research to alter visual cues during child and young adult development.
Thursday, April 30, 2026
The initiative provides eyecare professionals with a suite of downloadable materials they can share with their patients, including updated fact sheets, social media graphics, expert and patient video content, and a new podcast episode.
Thursday, April 30, 2026
AI Scribe operates directly inside the RevolutionEHR encounter workflow, capturing provider commentary during exams and automatically populating structured chart fields for review and approval.
Thursday, April 30, 2026
In the campaign, animated characters engage in everyday eye-related situations to raise awareness and prioritize eye health and safety.
Wednesday, April 29, 2026
The garment industry in South Asia, as well as the GDPs of several countries, could also see positive impacts from vision intervention.
Wednesday, April 29, 2026
Periorbital transcutaneous electrical stimulation may improve blinking and reduce dry eye signs and symptoms
Wednesday, April 29, 2026
Claire unifies data for actionable insights so clinicians can efficiently meet MIPS requirements and maximize program performance, the company said.
Wednesday, April 29, 2026
Eric Rosenberg, DO, MSE, performed the procedure at SightMD's advanced surgical facility in October. This is the first time a cataract surgeon has used a spatial computing headset as the primary visualization interface.
Tuesday, April 28, 2026
The study met the 12-month primary endpoint and met statistical significance and clinical relevance.
Tuesday, April 28, 2026
Prevent Blindness is set to launch its 2026 Focus on Eye Health Webinar Series on May 19, introducing a yearlong program centered on the theme “Powering Partnerships to Advance Eye Health.”
Monday, April 27, 2026
Professors Craig, Jones, and Wolffsohn help eyecare professionals understand and apply the TFOS DEWS III Report recommendations.
Thursday, April 23, 2026
This development allows eyecare professionals to conduct remote refractions efficiently, confidently, accurately, and consistently, the company said.
Thursday, April 23, 2026
The Hayes Center for Practice Excellence Award recognizes a graduate of the past 10 years who owns and operates a private optometry practice.
Wednesday, April 22, 2026
The portfolio is intended to be a comprehensive offering for these patients, the company said.
Wednesday, April 22, 2026
Clinicians will receive actionable, research-driven strategies that can be implemented in practice immediately following the event, the Academy said in the announcement.
Wednesday, April 22, 2026
The collaboration will support research, education initiatives, and the development of new clinical guidelines for managing the ocular surface in surgical care.
Wednesday, April 22, 2026
Latinos en Optometry has introduced a new student-focused activity aimed at helping middle school and early high school students explore whether a career in optometry may be a good fit.
Tuesday, April 21, 2026
The agreement designates Marco Lombart as the exclusive US distributor for the Haag-Streit Lenstar 900 optical biometer and the Octopus 600 and Octopus 900 perimeters.
Tuesday, April 21, 2026
The company's Lacrifresh HydraPF and Lacrifresh HydraMaxPF preservative-free artificial tears are now available at Walmart stores and Walmart.com.
Tuesday, April 21, 2026
The campaign aims to raise awareness, educate, and inspire action to slow myopia progression in children, according to the company.
Thursday, April 16, 2026
Acuvue Vita for Astigmatism will now offer around-the-clock coverage in 10° increments up to -2.75 D cylinder.
Thursday, April 16, 2026
Bausch + Lomb’s ONE by ONE Recycling program has collected and recycled a total of 119,715,074 units, or 724,922 pounds, of used contact lenses, eye care, and lens care materials in the United States.
Thursday, April 16, 2026
New J-code for Epioxa, J2789, is set to become effective July 1, 2026
Wednesday, April 15, 2026
Features include longer activation life, greater fatigue resistance, and improvement in fade-back speed, the company says.
Wednesday, April 15, 2026
The full range includes 14.5 mm to 19.0 mm.
Wednesday, April 15, 2026
Programming will include scientific paper and poster presentations highlighting recent research and case studies, as well as section and special interest group (SIG) symposia.
Tuesday, April 14, 2026
The sessions will focus on business and clinical strategies to strengthen specialty lens practices.
Thursday, April 9, 2026
The sustainability program focuses on materials sourcing, manufacturing efficiency, and plastic waste mitigation.
Wednesday, April 8, 2026
Data on Luminopia was recently presented at the American Association for Pediatric Ophthalmology and Strabismus 51st Annual Meeting.
Wednesday, April 8, 2026
The Pentacam Cornea OCT combines Scheimpflug technology with a pericentric OCT scanning system.
Wednesday, April 8, 2026
Takeaways for ODs
Tuesday, April 7, 2026
The role supports bringing innovation to the aging eye, the company said.
Tuesday, April 7, 2026
According to Alcon, TruPlus is designed to increase depth of focus while maintaining high-quality distance vision.
Tuesday, April 7, 2026
The procedure was performed by Dr. Alexey Rapoport, with Dr. Robert Edward T. Ang of the Asian Eye Institute in Manila serving as principal investigator.
Tuesday, April 7, 2026
More Change Agents will translate to increased capacity to respond to action needed for myopia management
Tuesday, April 7, 2026
K.C. Pharmaceuticals, Inc. is voluntarily recalling over 3 million eye drops that were distributed nationwide due to lack of assurance of sterility.
Thursday, April 2, 2026
The new optical-forward pair of Ray-Ban Meta glasses support nearly all prescriptions, the company said.
Thursday, April 2, 2026
IDOC announced the launch of Easyvision, a new private label contact lens portfolio created exclusively for IDOC member practices.
Thursday, April 2, 2026
Latinos en Optometry has introduced 2 bilingual tools aimed at improving communication between patients and eyecare professionals.
Thursday, April 2, 2026
Parents are turning to search engines to decode nearly every aspect of their children’s behavior—except their vision—according to new research.
Thursday, April 2, 2026
Blink Collective is designed to spotlight the voices, perspectives, and experiences of optometry students and early-career optometrists.
Tuesday, March 31, 2026
Acquisition will bring 2 differentiated commercialized immunology medicines to Biogen with Empaveli and Syfovre.
Monday, March 30, 2026
Carbachol and brimonidine tartrate work together for increased efficacy.
Monday, March 30, 2026
The campaign will support campus life and pediatric patient care.
Friday, March 27, 2026
First patient receives a single dose of CTx001 gene therapy for geographic atrophy secondary to AMD.
Thursday, March 26, 2026
Hoya Vision Care has released a new sustainability update detailing progress under its “One Vision” program and outlining accelerated environmental and social commitments.
Thursday, March 26, 2026
Taking place June 25 to 27 in Chicago, the conference brings together opticianry professionals from across the United States for 3 days of education, networking, and industry discussion.
Thursday, March 26, 2026
The initiative is intended to raise awareness that women face a higher risk of several vision conditions, including age-related macular degeneration, glaucoma, dry eye, and vision changes linked to pregnancy and menopause.
Thursday, March 26, 2026
Crossover study shows greater IOP reduction and reduced medication waste.
Wednesday, March 25, 2026
Data showed meaningful improvements in patient-reported quality-of-life outcomes with urcosimod.
Wednesday, March 25, 2026
Twelve-month data from Ocugen’s ArMaDa study support progression toward phase 3.
Tuesday, March 24, 2026
EYE7 smart glasses integrate an AI assistant to enhance independence for people with vision loss.
Tuesday, March 24, 2026
The new feature allows surgeons to demonstrate the visual effects of monovision during the consultation process.
Monday, March 23, 2026
SYD-101 0.01% significantly reduced myopia progression across all time points tested and met the primary efficacy endpoint at 36 months of confirmed myopia progression of -0.75 D or worse.
Monday, March 23, 2026
The online tool supports optometrists worldwide to easily evaluate and manage dry eyes in their patients.
Friday, March 20, 2026
Vision Expo 2026 concluded March 14 at the Orange County Convention Center, marking the event’s 40th anniversary and the debut of a unified annual format that brought together the global optical industry for 4 days of business, education, and product discovery.
Friday, March 20, 2026
Prevent Blindness has designated March 23-29 as its first Keratoconus Week, an awareness initiative focused on education and early detection of the eye disease.
Friday, March 20, 2026
Registration has opened for the 2026 Retina Summit, a 1-day continuing education program focused on retinal disease, scheduled for April 18 in Indianapolis.
Wednesday, March 18, 2026
Retrospective cohort shows 79% of patients improved without surgery, with measurable gains in divergence and reduced esodeviation
Wednesday, March 18, 2026
Clinic-based study suggests sex differences in preferred contact lens under-correction during presbyopia management
Wednesday, March 18, 2026
Survey finds widespread smoking status screening among optometrists in Wales following national training requirements.
Tuesday, March 17, 2026
Both companies mutually end deal after prolonged regulatory review.
Tuesday, March 17, 2026
Aldeyra said it does not currently expect to pursue additional clinical trials, and intends to expeditiously request a Type A meeting to understand the actions needed for NDA approval.
Friday, March 13, 2026
Nanodropper introduces a quiz designed to help patients assess challenges with topical therapies.
Friday, March 13, 2026
The ingredients are designed for comfortable absorption and application to the eyelid area.
Thursday, March 12, 2026
According to Heru, PretestPro allows full-stack pretesting in just under 2 minutes.
Thursday, March 12, 2026
LED Pro lenses are a patented ophthalmic lens technology engineered to selectively absorb the intense wavelengths that cause visual discomfort in white LED lighting.
Thursday, March 12, 2026
The extended depth of focus lens expands Johnson & Johnson’s cataract surgery portfolio.
Wednesday, March 11, 2026
The Vision Council issued an update after the Department of Justice, acting on behalf of US Customs and Border Protection, submitted a new proposal on March 6 outlining how refunds for duties assessed under the International Emergency Economic Powers Act could be processed.
Wednesday, March 11, 2026
The new brand reflects the company’s expansion beyond visual field testing to a broader diagnostic platform with integrated clinical workflows.
Wednesday, March 11, 2026
The January 2026 survey of US and Canadian contact lens patients indicated that 89% believe opticians are important in helping to achieve the best vision possible, with 83% saying opticians were extremely or very valuable to their contact lens-specific experience.
Wednesday, March 11, 2026
Transitions Optical has opened applications for its 2026 Transitions Optical Advancement educational grant program, which supports students pursuing careers in optometry and opticianry in the United States. The company is accepting submissions through April 17 at 11:59 PM ET.
Wednesday, March 11, 2026
Imports at major US container ports are projected to remain below last year’s levels during the first half of 2026 as retailers navigate continued tariff uncertainty, according to the latest Global Port Tracker report released by the National Retail Federation (NRF) and Hackett Associates.
Wednesday, March 11, 2026
Through a new partnership with Eyoto, DigitalOptometrics is introducing a new fully automated, remote-powered 4K digital slit lamp integrated into a tele-ophthalmic care platform.
Tuesday, March 10, 2026
Three optometry students were honored for their perspectives on technology’s expanding role in eyecare accessibility.
Tuesday, March 10, 2026
The expansion allows eyecare practices to access EVAA’s AI-powered billing automation and clinical documentation tools without changing their existing EHR system.
Monday, March 9, 2026
The auto lensmeter and lens verification system can help optical professionals analyze spherical power, cylinder, axis, prism, segment height, and optical center positioning for accuracy.
Monday, March 9, 2026
New features include intelligent note reconciliation, expanded device compatibility, and streamlined documentation.
Friday, March 6, 2026
The Vision Council has released its latest research report, “Provider inSights Q3-Q4 2025,” that provides an overview of economic conditions and operational trends among US eyecare practices during the second half of 2025.
Friday, March 6, 2026
These scholarships recognize outstanding optometry students who demonstrate academic excellence, leadership, and dedication to advancing the profession.
Thursday, March 5, 2026
Classroom initiative expands eye health education and career awareness in schools serving Hispanic/Latino communities
Wednesday, March 4, 2026
The program’s practice-ready infographics, social media graphics, animations, and more now include additional guidance for keeping contact lenses away from water, along with removal-related videos.
Wednesday, March 4, 2026
In his new role, Dr. Kramer will support Valley Contax’s growing focus on education and clinical collaboration.
Wednesday, March 4, 2026
VSP Vision announced a $1 million investment to expand access to vision care and literacy resources for children and families across the United States.
Wednesday, March 4, 2026
Global Myopia Awareness Coalition also announced that Meredith Bishop and Roni Kennison will serve as co-chairs.
Wednesday, March 4, 2026
The finalists of the 2026 Now Awards have been announced, spanning independent, licensed, emerging, and direct-to-consumer brands from the global eyewear community. Winners will be announced at a ceremony during the optical trade show, and all submissions will be on display throughout the event.
Friday, February 27, 2026
VSP Vision has named John Luder as the 2026 recipient of the Dr. Frank D. Fontana Memorial Scholarship, honoring his commitment to patient care, clinical excellence, and community outreach.
Friday, February 27, 2026
The browser-based software application is designed to enable eyecare professionals to work together more seamlessly by securely sharing data, referring patients, and strengthening their professional networks.
Thursday, February 26, 2026
The articles highlight the use of the Biovance 3L Ocular tri-layer decellularized basement membrane used in ocular surgery and in ocular surface disease applications.
Thursday, February 26, 2026
If approved, phentolamine ophthalmic solution 0.75% has the potential to offer a pharmacologic treatment option for patients seeking improved visual acuity without reliance on corrective lenses, the company said.
Thursday, February 26, 2026
Marking its 40th anniversary, Vision Expo will bring together the optical community for 4 days of product launches, accredited education, hands-on demonstrations, and networking opportunities March 11-14 at the Orange County Convention Center in Orlando, Florida.
Thursday, February 26, 2026
As part of Workplace Eye Wellness Month in March, Prevent Blindness provides free educational materials that eyecare professionals can share with their patients, designed to help employees and employers protect and maintain eye health.
Thursday, February 26, 2026
Colormax.org, a division of Global Complex Eye Care, announced an expansion of its custom contact lens system designed specifically to help individuals who have color blindness pass standardized color vision tests.
Thursday, February 26, 2026
This lens-to-invoice matching system enables practitioners to quickly verify lens parameters during the fitting process.
Thursday, February 26, 2026
VSP Vision Care has released new findings indicating that US employees are spending close to 100 hours per week on screens, with many reporting productivity challenges linked to screen-related visual discomfort.
Thursday, February 26, 2026
In response to the US Supreme Court’s 6–3 decision limiting presidential authority under the International Emergency Economic Powers Act (IEEPA), The Vision Council (TVC) hosted a webinar to brief members on the implications of the ruling and resulting changes to US tariff policy.
Wednesday, February 25, 2026
A new global review highlights the increasing prevalence of noninfectious ocular redness due to digital eye strain, dry eye disease, allergies, and environmental exposures.
Monday, February 23, 2026
The artificial tear is preservative free, blur free, lipid based, and safe for contact lens wearers, according to the company.
Monday, February 23, 2026
Findings from a retrospective study demonstrate statistically significant symptom improvement among patients prescribed Neurolens with Contoured Prism technology.
Monday, February 23, 2026
A ruling from the US Supreme Court has struck down sweeping global tariffs imposed under the International Emergency Economic Powers Act (IEEPA), invalidating tariffs on imports from several major US trading partners.
Thursday, February 19, 2026
The newly opened Malaysia Plant is dedicated exclusively to producing 1-day lenses.
Thursday, February 19, 2026
Prevent Blindness has declared the third annual Retinopathy of Prematurity (ROP) Awareness Week, Feb. 23 to March 1, as part of its ongoing ROP Education and Support Initiative.
Wednesday, February 18, 2026
The expansion extends EVO ICL use for patients 21 to 60 years old
Tuesday, February 17, 2026
Total30 Multifocal for Astigmatism is the only monthly multifocal toric contact lens with Water Gradient Technology, according to Alcon.
Monday, February 16, 2026
A new study finds nearly half of all people facing cataract-related blindness worldwide still need access to surgery.
Monday, February 16, 2026
The session will explore how culture, trust, and communication influence patient understanding and follow-through in chronic disease care.
Friday, February 13, 2026
The upgrade allows patients to schedule appointments, send and receive secure messages, pay bills online, and access clinical documents, including Consolidated Clinical Document Architecture records, through a single, secure destination
Friday, February 13, 2026
The lenses are indicated for use in the reduction of refractive error in nondiseased eyes.
Thursday, February 12, 2026
The World Council of Optometry (WCO) and World Optometry Foundation (WOF) announced the appointment of Dr. Juan Carlos Aragón (Costa Rica) and Dr. Scott Mundle (Canada) to the WOF Board of Trustees.
Thursday, February 12, 2026
Under the agreement, MeiraGTx will receive exclusive rights to ZipBio's first-in-class therapies for geographic atrophy, targeting the complement pathway.
Thursday, February 12, 2026
Researchers from the National Institutes of Health use AI to develop a 3D atlas of healthy and diseased RPE cell states.
Thursday, February 12, 2026
To mark the milestone, the company hosted “Global and Japanese Perspectives on Myopia Control in Tokyo” on January 27.
Wednesday, February 11, 2026
The 8-week virtual course provides participants with foundational knowledge in anatomy, ocular disease, diagnostics, optics, and patient safety.
Monday, February 9, 2026
At 6 months, children aged 4-12 wearing Miyosmart iQ spectacle lenses showed no myopia progression on average, with minimal eye growth, according to Hoya Vision Care.
Friday, February 6, 2026
The global competition is designed to identify and support early-stage companies developing technologies and solutions aimed at advancing the eyecare experience.
Thursday, February 5, 2026
Ametek has announced its acquisition of LKC Technologies.
Thursday, February 5, 2026
The alliance aims to preserve and grow the private practice market segment, improve profitability, and lessen financial pressures on optometry practices.
Thursday, February 5, 2026
Vision Expo is marking its 40th anniversary by inviting longtime attendees and exhibitors to contribute to a commemorative retrospective highlighting the event’s history and impact on the optical industry.
Thursday, February 5, 2026
Clinique and Acuvue will roll out a multichannel consumer education campaign featuring expert-driven content, engaging digital activations, and consumer experiences.
Friday, January 30, 2026
Registration is now open for Optometry’s Meeting and AOA+, taking place June 17-20 in Phoenix. The annual event will feature more than 300 hours of programming planned across clinical, technological, and practice management topics.
Friday, January 30, 2026
Congress’s finalized funding for fiscal year 2026 includes cuts to the Centers for Disease Control and Prevention's Vision and Eye Health program, reducing its budget by nearly one-third, according to Prevent Blindness.
Thursday, January 29, 2026
Each Visionary has demonstrated a commitment to raising awareness of advances in soft contact lenses and prescribing benefits.
Thursday, January 29, 2026
Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, is the first dual-agent eye drop for the treatment of presbyopia in adults.
Thursday, January 29, 2026
According to The Vision Council’s “Market inSights 2025 With 2026 Forecast,” the US optical industry grew in overall value in 2025, reaching an estimated $69.5 billion, even as the number of products purchased and eye exams conducted declined.
Thursday, January 29, 2026
The patent protects the core clinical reasoning framework behind CSI Dry Eye Software.
Tuesday, January 27, 2026
Prevent Blindness is providing free educational resources on AMD and low vision including patient and expert videos, webpages, fact sheets, and more.
Tuesday, January 27, 2026
The collaboration will bring more innovations in dry eye disease tools and resources.
Tuesday, January 27, 2026
The meetings focused on concerns that rising costs tied to current trade policies are affecting optical businesses, independent practices, and patient access to prescription eyewear.
Tuesday, January 27, 2026
In an imaging study from the Bascom Palmer Eye Institute, Qlosi's low-concentration formulation with 0.4% pilocarpine significantly reduced pupil diameter while demonstrating ciliary muscle movement the same as balanced salt solution control.
Monday, January 26, 2026
The World Council of Optometry (WCO) announced that World Optometry Week 2026, running March 22-28, will highlight coordinated, cross-sector collaboration as a strategy for expanding access to eye and vision care worldwide.
Thursday, January 22, 2026
The kit features a custom compounded topical medicated ointment containing ivermectin 1%, metronidazole 0.5%, and tea tree oil 0.3%, with 2 OCuSOFT products to support a comprehensive eyelid hygiene routine.
Wednesday, January 21, 2026
OCuSOFT’s Retaine Omega Forté contains a concentrated daily dose of omega-3 essential fatty acids in natural triglyceride form.
Tuesday, January 20, 2026
Nationwide study reports factors including gender disparities, home life, and work life that contribute
By Sarah Fackler, managing editor, Optometric Management and Eyecare Business
Tuesday, January 20, 2026
The preservative-free eye drops are available in single-dose vials.
Tuesday, January 20, 2026
Dr. Reddy’s olopatadine hydrochloride ophthalmic solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander, the company says.
Friday, January 16, 2026
This collaboration leverages ABB Labs' United States-based footprint and established relationships with independent optometry.
Friday, January 16, 2026
The American Optometric Association, buoyed by dedicated Third Party Center committee doctor volunteers, celebrates ongoing wins for optometrists.
Thursday, January 15, 2026
The planned consolidation marks a major expansion for Nanodropper, evolving the company from a single-product device manufacturer into a broader commercial-stage medtech ecosystem.
Thursday, January 15, 2026
TheraTears announced 2 new additions to its portfolio launching nationwide in February 2026: TheraTears Eyelid Cleansing Wipes and TheraTears Dry & Tired Preservative Free Lubricant Eye Drops.
Thursday, January 15, 2026
The partnership concluded on December 31, 2025.
Thursday, January 15, 2026
The event spotlighted the central role of ECPs in shaping the future of myopia care, bringing together clinical evidence, real-world outcomes, and emerging best practices.
Thursday, January 15, 2026
The new integration enables eyecare practitioners to import corneal topography data directly into the software for designing and customizing specialty contact lenses.
Thursday, January 15, 2026
Professional Eye Care Associates of America (PECAA) announced that registration is now open for its 2026 Annual Meeting, scheduled for May 17-19 at the Manchester Grand Hyatt in San Diego.
Thursday, January 15, 2026
The initiative invites VSP network doctors to apply for support to expand access to eye care in their local communities.
Tuesday, January 13, 2026
Menicon and AAOS will work together to provide enhanced resources and opportunities for optometrists that include access to premium products, educational resources, and community engagement.
Tuesday, January 13, 2026
Positive clinical data shows improvement in visual function in patients with infantile nystagmus
Tuesday, January 13, 2026
A large randomized clinical trial conducted in China found that a form of noninvasive electrical eye stimulation reduced the incidence of myopia in children identified as being at risk for the condition.
Thursday, January 8, 2026
Vision Expo 2026 will mark the event’s 40th year with an expanded educational conference and a unified annual format.
Thursday, January 8, 2026
The lenses are built on technology exclusively licensed from the Brien Holden Vision Institute.
Thursday, January 8, 2026
BluTech to manufacture the next generation of Avulux migraine and light sensitivity lenses.
Tuesday, January 6, 2026
The new lens combines the MiSight 1 day ActivControl Technology with silicone hydrogel material used in MyDay lenses, the company says.
Friday, January 2, 2026
The Digest reflects a global expert consensus on the definitions, risk factors, prevention, and management of myopia in children and young adults.
Friday, January 2, 2026
Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision.
Friday, January 2, 2026
The American Academy of Optometry (AAO) has opened its call for course proposals for the educational program at Academy 2026 Anaheim, inviting optometrists and educators to submit lectures, workshops, and interactive sessions for consideration.
Friday, January 2, 2026
Together, the Eye Surface Profiler and the Xwave aberrometer provide a unified solution, according to the company.
Friday, January 2, 2026
As part of National Glaucoma Awareness Month in January, Prevent Blindness announced the availability of free educational resources on glaucoma that eyecare professionals can share with their patients.
Affiliations:
Specialties:
Areas of Expertise: